Correction
Our recently published review article [1] contained a misprint. On page four under the sub-heading 'Goal-directed fluid therapy' and in the third paragraph, the sentence:
"Results of a randomized trial investigating mortality in 3,141 children with severe febrile illness and impaired perfusion in sub-Saharan Africa surprisingly showed higher mortality at 48 hours and at 4 weeks in the group that did not receive any fluid boluses compared with two groups resuscitated with albumin or saline 38."
should have instead read:
"Results of a randomized trial investigating mortality in 3,141 children with severe febrile illness and impaired perfusion in sub-Saharan Africa surprisingly showed lower mortality at 48 hours and at 4 weeks in the group that did not receive any fluid boluses compared with two groups resuscitated with albumin or saline 38."
The authors sincerely regret this error.
Competing interests
TJG has received research funding from Fresenius Kabi and honoraria from Hospira and Baxter. KB and RHT declare that they have no competing interests.
See related review by Bartels et al., http://ccforum.com/content/17/S1/S6
References
- Bartels K, Thiele R, Gan T. Rational fluid management in today's ICU practice. Critical Care. 2013;17(Suppl 1):S6. doi: 10.1186/cc11504. [DOI] [PMC free article] [PubMed] [Google Scholar]